RT Journal Article
SR Electronic
T1 fNIRS-derived Neurocognitive Ratio as a Biomarker for Neuropsychiatric Diseases
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.10.21256934
DO 10.1101/2021.05.10.21256934
A1 Ata Akın
YR 2021
UL http://medrxiv.org/content/early/2021/05/12/2021.05.10.21256934.abstract
AB Significance Clinical use of fNIRS derived features has always suffered low sensitivity and specificity due to signal contamination from background systemic physiological fluctuations. This article provides an algorithm to extract cognition related features by eliminating the effect of background signal contamination; hence, improves the classification accuracy.Aim The aim in this study is to investigate the classification accuracy of an fNIRS derived biomarker based on global efficiency. To this end, fNIRS data were collected during a computerized Stroop Task from healthy controls, and patients with migraine, obsessive compulsive disorder, and schizophrenia.Approach Functional connectivity (FC) maps were computed from [HbO] time series data for Neutral, Congruent and Incongruent stimuli using the partial correlation approach. Reconstruction of FC matrices with optimal choice of principal components yielded two independent networks: Cognitive Mode Network (CM) and Default Mode Network(DM).Results Global Efficiency (GE) values computed for each FC matrix after applying principal component analysis yielded strong statistical significance leading to a higher specificity and accuracy. A new index, Neurocognitive Ratio (NCR), was computed by multiplying the Cognitive Quotients (CQ) and ratio of GE of CM to GE of DM. When mean values of NCR over all stimuli were computed, they showed high sensitivity (100%), specificity (95.5%), and accuracy (96.3%) for all subjects groups.Conclusions can reliable be used as a biomarker to improve the classification of healthy to neuropsychiatric patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementIncluded in the paperAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The 75 study protocol was approved by the Ethics Committee of Pamukkale Univer- 76 sity in 2008. Parts of these data were published by our group and coworkers 77 [13, 14, 15, 16, 17, 18, 19, 20, 21, 22]. Consents were obtained from all subjects 78 and they were all informed about the study before the experiment.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and codes can be provided upon request to the author when found appropriate